DOT1L methylates histone H3K79 and is aberrantly regulated in MLL-rearranged leukemia. Inhibitors 33 have been developed to target DOT1L activity in leukemia but the cellular mechanisms that regulate 34 DOT1L are still poorly understood. Here we identify the budding yeast histone deacetylase Rpd3 as a 35 negative regulator of Dot1. At its target genes, the transcriptional repressor Rpd3 restricts H3K79 36 methylation, explaining the absence of H3K79me3 at a subset of genes in the yeast genome. Similar to 37 the crosstalk in yeast, inactivation of the murine Rpd3 homolog HDAC1 in thymocytes led to an 38 increase in H3K79 methylation. Thymic lymphomas that arise upon genetic deletion of Hdac1 retained 39 the increased H3K79 methylation and were sensitive to reduced DOT1L dosage. Furthermore, cell 40 lines derived from Hdac1 Δ/Δ thymic lymphomas were sensitive to DOT1L inhibitor, which induced 41 apoptosis. In summary, we identified an evolutionarily-conserved crosstalk between HDAC1 and 42 DOT1L with impact in murine thymic lymphoma development. 43
Introduction 44
Aberrant histone modification patterns have been observed in many diseases and this deregulation of 45 chromatin can play a causative role in disease. Since epigenetic alterations are, in principle, reversible 46 in nature, histone (de)modifiers are attractive therapeutic targets (Brien et al. 2016; Jones et al. 2016 ; Shortt et al. 2017) . Several epigenetic drugs are currently in the clinic or in clinical trials, but for many 48 of the drug targets we are only beginning to understand their cellular regulation. 49
The histone H3K79 methyltransferase DOT1L (KMT4; Dot1 in yeast) is an epigenetic enzyme for which 50 inhibitors are in clinical development for the treatment of MLL-rearranged (MLL-r) leukemia (Stein and 51 Tallman 2016). In MLL-r leukemia, DOT1L recruitment to MLL target genes, such as the HoxA cluster 52 leads to aberrant H3K79 methylation and increased transcription (reviewed in Vlaming and Van 53 Leeuwen 2016). Although the DOT1L inhibitor Pinometostat (EPZ-5676) has shown promising results 54 in the lab and is currently in clinical development (Bernt et An important mechanism of regulation is the trans-histone crosstalk between monoubiquitination of 58 the C terminus of histone H2B (H2Bub) at lysine 120 (123 in yeast) and methylation of histone H3K79 59 (Zhang et al. 2015) . The addition of a ubiquitin peptide to the nucleosome at this position occurs in a 60 co-transcriptional manner and promotes the activity of Dot1/DOT1L, possibly by activation of DOT1L 61 or coaching it towards H3K79 and thereby increasing the chance of a productive encounter (Zhou et DOT1L could lead to the identification of alternative drug targets for diseases in which DOT1L is critical 68 and provide alternative strategies in case of resistance to treatment with DOT1L inhibitors (Campbell 69 et al. 2017) . 70
In a previous study, we presented a ChIP-barcode-seq screen (Epi-ID) identifying novel regulators of 71 H3K79 methylation in yeast ). The Rpd3-large (Rpd3L) complex was identified as 72 an enriched complex among the candidate negative regulators of H3K79 methylation of a barcoded 73 reporter gene. Rpd3 is a class I histone deacetylase (HDAC) that removes acetyl groups of histones, as 74 well as numerous non-histone proteins, and is generally associated with transcriptional repression 75 (Yang and Seto 2008) . Several inhibitors of mammalian HDACs have been approved for the treatment 76 of cutaneous T-cell lymphoma and other hematologic malignancies, while others are currently being 77 tested in clinical trials (West and Johnstone 2014) . HDAC1 and HDAC2, prominent members of the 78 class I HDACs, are found in the repressive Sin3, NuRD, and CoREST complexes (Yang and Seto 2008) . 79
Loss or inhibition of HDAC1/Rpd3 leads to increased histone acetylation, which in turn can lead to 80 increased expression of target genes and cryptic transcripts (Carrozza et Here, we demonstrate that Rpd3 restricts H3K79 methylation at its target genes. Most euchromatic 83 genes in the yeast genome are marked by high levels of H3K79me3. We observed that a subset of the 84 genes that do not follow this pattern has lower H3K79me3 levels due to the action of the Rpd3L 85 complex, which deacetylates its targets and imposes strong transcriptional repression and absence of 86 H2Bub1. Importantly, the Rpd3-Dot1 crosstalk is conserved in mammals: genetic ablation of Hdac1 in 87 murine thymocytes also leads to an increase in H3K79 methylation in vivo. High H3K79me is 88 maintained in the lymphomas these mice develop, and a reduction in DOT1L activity by heterozygous 89 deletion of Dot1L reduces tumor burden, an effect that was not observed upon homozygous deletion 90 of Dot1L. Furthermore, DOT1L inhibitors induce apoptosis in Hdac1-deficient but not Hdac1-proficient 91 thymic lymphoma cell lines, suggesting a DOT1L-dose dependence. Taken together, our studies reveal 92 a new, evolutionarily-conserved mechanism of H3K79me regulation by Rpd3/HDAC1 with relevance 93 for cancer development. 94
Results 95
96
Identification of the Rpd3L complex as a negative regulator of H3K79 methylation 97
We recently reported a systematic screening strategy called Epi-ID to identify regulators of H3K79 98 methylation ). In that screen, relative H3K79 methylation (H3K79me) levels at two 99 DNA barcodes (UpTag and DownTag) flanking a reporter gene were measured in a genome-wide 100 library of barcoded deletion mutants, thus testing thousands of genes for H3K79me regulator activity 101 at these loci ( Fig. 1A ). Since higher Dot1 activity in yeast leads to a shift from lower (me1) to higher 102 (me3) methylation states (Frederiks et al. 2008) , the H3K79me3 over H3K79me1 ratio was used as a 103 measure for Dot1 activity. A growth-corrected H3K79me score was calculated to account for the effect 104 of growth on H3K79 methylation and groups of positive and negative candidate regulators were 105 identified Deletion of the two Rpd3S-specific subunits did not lead to an increase in H3K79me ( Fig. 1B) , which is 113 consistent with Rpd3S binding and acting on coding sequences (Drouin et al. 2010 ) and thus away 114 from the intergenic barcodes. To validate the effect on a global scale, we performed targeted mass 115 spectrometry analysis to determine the relative levels of the different H3K79me states (me0 to me3) 116 in rpd3Δ and sin3Δ strains. On bulk histones, these strains showed an increase in H3K79me (increase 117 in H3K79me3 at the cost of lower methylation states; Fig. 1C ). The H3K79me increase was not caused 118 by an increase in Dot1 protein (Supplemental Fig. 1A ) or mRNA expression . 119
Thus, although these regulators were identified using only two 20-base-pair barcodes to read out 120 H3K79me levels at a reporter locus, their effects could be validated globally. 121 122 Rpd3 represses H3K79 methylation at the 5' ends of a subset of genes 123
We next asked at which regions Rpd3 and Sin3 regulate H3K79 methylation in yeast, other than the 124 barcoded reporter gene. To address this, we performed ChIP-seq analysis for H3K79me1, H3K79me3, 125 and H3 in wild-type and rpd3Δ strains. In addition, we included ChIP-seq for H2B and H2Bub using a 126 site-specific antibody that we recently developed (Van Welsem et al. 2018). First, we considered the 127 patterns in the wild-type strain. Both the coverage at one representative locus and across all genes in 128 a heatmap showed that H3K79me3 is predominantly present throughout coding sequences of most 129 genes, where H2Bub is also high, as reported previously ( We then compared the patterns in wild-type versus rpd3Δ mutant strains. In metagene plots, the 141 mutant showed a decrease in H3K79me1 and an increase in H3K79me3 just after the transcription 142 start site (TSS; Supplemental Fig. 1B ), suggesting that in this region Rpd3 suppresses the transition 143 from lower to higher H3K79me states. To assess whether the changes observed in the metagene plots 144 were explained by a modest effect on H3K79me at all genes or a stronger effect at a subset of genes, 145 we determined the H3-normalized H3K79me3 level in the first 500 bp of each gene and ranked the 146 genes based on the change in H3K79me3 upon loss of Rpd3. A heatmap of H3K79me3 by this ranking 147 showed that the absence of Rpd3 leads to an increase of H3K79me3 at a subset of genes ( Fig. 1F ). 148 149 Rpd3 represses H3K79me at its target genes 150
To characterize the genes at which H3K79me is regulated, we calculated the levels of H3K79me1 and 151
H3K79me3 per gene in the same 500 bp window and plotted values in the rank order of H3K79me3 152 changes described above, using locally weighed regression ( Fig. 2A ; corresponding heatmaps can be 153 found in Supplemental Fig. 2A ). Inspection of these plots revealed that the ORFs on which H3K79me3 154 was increased in the rpd3Δ mutant showed a simultaneous decrease in H3K79me1 (groups III-IV; Fig Rpd3 loss had the highest Rpd3 occupancy, both at the promoter and in the 500 bp window 162 downstream of the TSS (group IV; Fig. 2A ). Rpd3 was also found to be active at these genes, since they 163 were devoid of H4 acetylation in wild-type cells and H4 acetylation was restored in the rpd3Δ mutant 164 ( Fig. 2A ). Finally, the top-regulated genes were also enriched for meiotic genes, which are known Rpd3 165 targets, and binding sites of Ume6, the Rpd3L subunit known to recruit Rpd3 to early meiotic genes 166 Notably, a small subset of genes loses H3K79me3 in the absence of Rpd3 (Fig. 1F , group I in Fig. 2A ). 170
This group of genes already has low H3K79me3 and H2Bub levels in wild-type cells and is highly 171 enriched for subtelomeric genes ( Fig. 2A, 2D ). Loss of Rpd3 is known to enhance Sir-mediated 172 silencing at subtelomeric regions (Ehrentraut et al. 2010 (Ehrentraut et al. , 2011 Gartenberg and Smith 2016; Thurtle-173 Schmidt et al. 2016). Our findings show that the stronger transcriptional silencing occurs with a 174 concomitant reduction in H3K79me3 and H2Bub in the coding regions of heterochromatic genes. 175
Whether or not the loss of these modifications contributes to the stronger silencing in rpd3Δ/sin3Δ 176 mutants or is a consequence of it remains to be determined. 177
178

Strong repression of H3K79me by Rpd3 coincides with repression of H2Bub and transcription 179
To understand the mechanistic basis for the crosstalk between Rpd3 and Dot1, we examined the 180 changes in H2B ubiquitination and transcription. The expression of the H2Bub machinery is not 181 deregulated in these mutants and no upregulation of H2Bub could be 182 detected by immunoblot (Supplemental Fig. 1A ). Because subtle changes can be missed by blot, we 183 proceeded to generate H2Bub ChIP-seq data in wild-type and mutant strains using an antibody we 184 recently described (Van Welsem et al. 2018). We found that the strongest H3K79me3 repression by 185 Rpd3 (group IV) coincided with repression of H2Bub as well as transcription ( Fig The H2B ubiquitination machinery is known to be recruited co-transcriptionally and promote H3K79 190 methylation, so transcriptional repression provides a likely explanation for the restriction of H3K79 191 methylation at these genes. However, despite these established causal links, there is no simple linear 192 relation between transcription level and H3K79me3 level, while H2Bub correlates with transcription 193 perfectly (Supplemental Fig. 2D ; Schulze et al. 2009 Schulze et al. , 2011 Weiner et al. 2015 ). It appears that other 194 processes counteract H3K79 methylation (see discussion), especially at highly transcribed genes, but 195 that these processes do not affect the Rpd3-regulated genes as much, since they form a subset of 196 genes at which transcription and H3K79me3, and their changes upon RPD3 deletion, are correlated. 197
In addition to genes where Rpd3 has a strong effect on H3K79me, we also observed genes at which 198 H3K79 methylation was more modestly affected by the deletion of RPD3 (group III; Fig. 2A ). Rpd3 is 199 found at the promoters of these genes, but H4 acetylation, transcription, and H2B ubiquitination are 200 not affected. Therefore, at these loci another, still unknown additional mechanism could be at play. 201
Taken together, we identified Rpd3 as a bona fide negative regulator of H3K79 methylation in yeast 202 that restricts H3K79me3 at its euchromatic targets, probably mostly by repressing target gene 203 transcription and H2Bub, but other mechanisms seem to be at play as well. 204
HDAC1 loss increases H3K79me in murine thymocytes 206
Having uncovered a role for Rpd3 in restricting H3K79me at its targets and finding that this can explain 207 a significant part of the H3K79 methylation variance between genes in yeast, we next wanted to 208 investigate the biological relevance of this regulation in mammals. Histone deacetylases are conserved 209 between species and can be divided into four classes (Yang and Seto 2008) . Rpd3 is a founding 210 member of the class I HDACs, which in mammals includes HDAC1, -2, -3 and -8. Of these, HDAC1 and -211 2 are found in Sin3 complexes, like yeast Rpd3 (Yang and Seto 2008) . Given that both HDACs and 212 DOT1L play critical roles in T-cell malignancies, we employed conditional early thymocyte-specific 213
Hdac1 deletion (Lck-Cre;Hdac1 f/f , resulting in Hdac1 Δ/Δ thymocytes) in the mouse to investigate 214 whether the regulation that we observed in yeast also exists in T cells. We focused on HDAC1 because 215 it is more active in mouse thymocytes than HDAC2 Dovey et al. 2013 ). First, we 216 measured the relative abundance of H3K79 methylation states on bulk histones by mass spectrometry 217 in wild-type and Hdac1-deleted thymocytes of 3-week-old mice (Fig. 3A) . In general, the overall levels 218 of H3K79 methylation were much lower than in yeast and H3K79me1 was the most abundant 219 methylation state, followed by H3K79me2, consistent with previous reports in mouse and human cells 220 lymphomas (1 out of 112). Also, Dot1L deletion alone (Lck-Cre;Dot1L f/f ) rarely led to thymic 243 lymphomas, with a 15% incidence in this background ( Fig. 3C, 3D ), and no cases of thymic lymphoma 244 in another background (data not shown). We then assessed the effect of Dot1L deletion in the Lck-245
Cre;Hdac1 f/f model. Loss of one copy of Dot1L increased survival rate and tumor latency (48% 246 incidence, comparison to Hdac1 f/f alone p=0.002; Fig. 3C, D) . This effect suggests that there is a causal 247 link between the increase in H3K79 methylation and the development or maintenance of thymic 248 lymphomas upon Hdac1 deletion. Interestingly, homozygous Dot1L deletion, leading to a complete 249 loss of H3K79me, did not extend the latency of thymic lymphomas (81% incidence, 15.7 weeks median 250 latency, comparison to Hdac1 deletion alone p=0.463; Fig. 3C, D) . A possible explanation is that the 251 simultaneous deletion of Dot1L and Hdac1 results in the generation of a different class of tumor that 252 does not depend on H3K79 methylation but has acquired other, possibly epigenetic, events that allow 253 oncogenic transformation. A similar model has been proposed for the loss of Hdac2 in the Lck-254
Cre;Hdac1 f/f model ). For the heterozygous Dot1L effect, we consider two 255 possible explanations: the oncogenic transformation occurred later because an additional event was 256 required to overcome the lack of high H3K79me, or tumors grew slower due to lower H3K79me, 257 either because of decreased proliferation or increased apoptosis. 258 259
Hdac1-deficient thymic lymphoma lines depend on DOT1L activity 260
To further study the Dot1L dependence of Hdac1-deficient thymic lymphomas in a more controlled 261 environment, we turned to ex vivo experiments. Cell lines were derived from Hdac1-deficient thymic 262 lymphomas ). Since these cell lines had an inactivating mutation in p53, cell lines 263 derived from p53-null thymic lymphomas were used as Hdac1-proficient control lines (Heideman et al. 264 2013) . First, we examined whether Hdac1-deficient tumor cells retained the increased H3K79 265 methylation levels seen prior to the oncogenic transformation. Both by immunoblot and by targeted 266 mass spectrometry on independent samples (Fig. 4A, 4B ), Hdac1-deficient tumor cell lines had more 267 H3K79 methylation than their Hdac1-proficient counterparts. Thus, the effect of HDAC1 on H3K79 268 methylation observed in vivo in 3-week old pre-malignant thymuses was maintained in the thymic 269 lymphoma cell lines. Importantly, Hdac1-deficient cell lines also possessed high levels of ubiquitinated 270 H2B compared to Hdac1-proficient controls (Fig. 4C ). High H2Bub is consistent with the increase in 271
H2Bub seen at Rpd3 targets in yeast. Therefore, a plausible model is that at least part of the observed 272 increase in H3K79me upon loss of HDAC1 activity is mediated via H2Bub, consistent with what we 273 observed in yeast. However, contributions from other regulatory mechanisms cannot be excluded (see 274 discussion). To test the DOT1L dependence of the cell lines, DOT1L was depleted using shRNAs in 275
Hdac1-proficient and -deficient cell lines. As can be seen in Figure 4D , shRNAs that reduce Dot1L 276 expression (Supplemental Fig. 4A ) affected proliferation of the Hdac1-deficient cell lines. Compared to 277 the control lines, the Hdac1-deficient cell lines were also more sensitive to two different DOT1L 278 inhibitors ( Fig. 4E ). Both inhibitors, EPZ-5676 (Pinometostat) and SGC-0946, effectively lowered H3K79 279 methylation (Supplemental Figure 4B ). Thus, shRNA-mediated DOT1L knockdown and chemical DOT1L 280 inhibition showed that the Hdac1-deficient thymic lymphoma cell lines depended on DOT1L activity. 281
The reduced growth upon inactivation of DOT1L could be explained by a block in proliferation or an 282 increase in cell death. To measure apoptosis induction, the levels of AnnexinV and DAPI staining of 283 non-permeabilized cells were determined by flow cytometry. In the DMSO-treated condition most 284 cells were alive, although Hdac1-deficient lines had a slightly higher basal apoptosis level ( Fig. 5A,B) . 285
This combination of proliferation and apoptosis has also been observed in Hdac1 Δ/Δ teratomas (Lagger 286 et al. 2010 ). However, DOT1L inhibition by 5μM of SGC-0946 dramatically induced apoptosis in Hdac1-287 deficient cells, whereas no effect on apoptosis was observed in the control cell lines (Fig. 5A,B ). Thus, 288 DOT1L inhibition induced apoptosis specifically in Hdac1-deficient thymic lymphoma cell lines. 289
Discussion 290
291
Here we describe that the yeast HDAC, Rpd3, is a negative regulator of H3K79 methylation that 292 restricts methylation at the 5' ends of its target genes. Similar to what we observe for Rpd3 in yeast, 293
deleting Hdac1 in murine thymocytes leads to an increase in H3K79 methylation. This regulation is 294 relevant in a cancer context, since heterozygous deletion of Dot1L prolongs the survival of mice that 295 H3K79me ChIP-seq in yeast revealed that Rpd3 restricts H3K79me3 at its direct target genes. This 313 subset of genes showed great overlap with the minority of euchromatic genes that is marked with 314 H3K79me1 instead of H3K79me3. Thus, the regulation by Rpd3 provides an explanation for the 315 variation in H3K79 methylation between genes and thereby seems to be an important determinant of 316 the H3K79 methylation pattern. The H3K79me effect of Rpd3 was most notable at the 5' end of genes, 317 which is in agreement with previous studies on Rpd3 activity. The deacetylation activity of 318 Rpd3/Rpd3L is reported to be strongest in coding sequences, particularly at the 5' ends (Weinberger 319 et al. 2012) . At which genes HDAC1 regulates H3K79 methylation in murine thymocytes is an 320 interesting question, but addressing it is not straight-forward. Unlike in yeast, in mammals H3K79 321 methylation is tightly linked to the transcriptional activity at genes. Processes through which 322 transcription promotes H3K79 methylation are known, but in turn, H3K79 methylation may affect 323 transcription as well (reviewed in Vlaming and Van Leeuwen 2016). Therefore, while assessing 324
H3K79me changes in Hdac1-deficient cells, it will be challenging to separate direct effects from 325 indirect effects on DOT1L activity through transcriptional changes. The generation and crosses of the conditional knock-out mice is described in the Supplemental 401
Methods. Mice were monitored over time, up to 40 weeks of age. A power analysis performed 402 beforehand determined group sizes of 20-25 mice per genotype. Mice were sacrificed before 40 403 weeks when they displayed breathing issues caused by the thymic lymphoma, or serious discomfort 404 unrelated to tumor formation. After death or sacrifice, mice were checked for the presence of a 405 thymic lymphoma. Mice that died without a lymphoma were censored in the survival curves. Mice of 406 which the cause of death could not be determined were left out of the survival curve, together with 407 their littermates. All experiments were approved by a local ethical committee and performed 408 according to national guidelines. Mice were housed under standard conditions of feeding, light and 409 temperature with free access to food and water. 410
Protein lysates, immunoblots and mass spectrometry 411
Yeast whole-cell extracts were made as described previously (Vlaming et al. 2014) . Nuclear extracts 412 were prepared of murine cells, see supplemental methods for details. The immunoblotting procedure 413 was as described in (Vlaming et al. 2014 ). All antibodies used in this study are listed in the 414 supplemental methods. Mass spectrometry measurements on yeast strains and thymic lymphoma cell 415 lines were as described in (Vlaming et al. 2014) . Measurements on thymus tissue were performed 416 using the method described in . 417 418
ChIP-sequencing and ChIP-qPCR 419
ChIP and ChIP-qPCR experiments were performed as described before ). Primers 420 for qPCR are shown in Supplemental Table 2 . Details on the ChIP-seq library preparation and the first 421 analysis steps are provided in the Supplemental Methods. In short, preparation and sequencing were 422 performed by the NKI Genomics Core Facility. Reads were mapped to the Saccharomyces cerevisiae 423 reference genome R64-2-1 and extended to 150 bp. Samples were depth-normalized, and when data 424 from biological duplicates was found to be similar, data sets were merged for further analyses. 425
Metagene plots and heatmaps were generated with custom scripts in R/Bioconductor (Cherry et al. 426 2012; Huber et al. 2015) . Reads were aligned in a window of -500 to 1 kb around the TSS of each 427 verified ORF recorded in SGD. Genes that contained a coverage of 0 or an average coverage in the first 428 500 bp below 0.5 were filtered out (leaving 5006 out of 5134 genes). For heatmaps, the coverage was 429 grouped in bins of 10 bp. The plots in Figure 2A The accession number for the ChIP-seq results reported in this study is GSE107331. 486 487
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Kruijsbergen, Tineke Lenstra, and Maarten van Lohuizen for critically reading the manuscript. A) Mass spectrometry analysis of H3K79 methylation in thymuses from 3-week-old mice, either wild-type (Cre-) or with deleted Hdac1 or Dot1L alleles, as indicated. Mean and individual data points of biological replicates; H3K79me0 is the predominant state, the y axis is truncated at 70% for readability. The remaining H3K79 methylation after homozygous Dot1L deletion is probably due to the presence of some cells in which Cre is not expressed (yet). B) Representative H&E and immunohistochemical stainings of thymic lymphomas of the indicated genotypes. A picture with lower magnification is included in Supplemental Fig.  3B . C) Kaplan-Meier curves of mice harboring thymocytes with indicated genotypes. An event was defined as death or sacrifice of a mouse caused by a thymic lymphoma. Mice that died due to other causes or were still alive and event-free at the end of the experiment were censored. Mice for which the cause of death could not be determined were removed from the data. Wild-type mice were the Cre-littermates of the mice that were used for the other curves. D) Summary of the data presented in panel C. A median latency could only be calculated when the tumor incidence was >50%. The p value was determined by comparing to the Lck-Cre;Hdac1 f/f curve with a Peto test, but a logrank test yielded the same conclusions. 
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Supplemental Table 1 Yeast strains used in this study Supplemental Table 2 Primers used for qPCR Supplemental Figure 1 Rpd3 and Sin3 negatively regulate H3K79 methylation
Supplemental Figure 2
ChIP-seq and ChIP-qPCR data from WT vs rpd3Δ cells and the relation between transcription and histone modifications Supplemental Figure 3 The A) Immunoblots show that deletion of RPD3 or SIN3 does not lead to a detectable increase in global H2Bub or Dot1 protein levels. B) Metagene plots of H3K79me1, H3K79me3, H2Bub, H3, and H2B in rpd3Δ and wild-type strains. C) Gene set enrichment analysis shows that subtelomeric genes (<30 kb of telomeres) are enriched among genes with low H3K79 methylation (measured by the average H3K79me3/H3K79me1 ratio in the first 500 bp of the ORF). D-E) Snapshots of depth-normalized ChIP-seq data tracks from wild-type and rpd3Δ strains showing 7 kb surrounding the meiotic gene ZIP1 (D), and telomeric genes AIF1 and COS10 (E). All tracks have the same y axis (0-2), which, for comparison, is also the same scale as in Fig. 1E . 
qPCR data from WT vs rpd3Δ cells and the relation between transcription and histone modifications.
A) Heatmaps of H3K79me1, H3K79me3, H2Bub and H3 sorted on H3K79me3/H3 rpd3Δ/WT. B) H2B-normalized H2Bub ChIP-qPCR IP efficiencies at several pre-selected loci in wild-type and rpd3Δ cells, with bre1Δ cells serving as a negative control. C) H2Bub ChIP-qPCR IP efficiencies at several pre-selected loci in wild-type and rpd3Δ cells, with bre1Δ cells serving as a negative control. D) ChIP-seq and RNA-seq data for genes ranked on transcription level in wild-type cells, smoothed using locally weighed regression. The shaded band around the line shows the 95% confidence interval. For H3K79me1, H3K79me3, H2Bub, H4ac and Rpd3 binding to ORF, the average coverage in the first 500 bp was used. Rpd3 binding to promoter was the average coverage in the 400 bp upstream of the TSS. Transcription in wild-type cells Figure 4D . The shRNAs 1 and 2 give a knockdown of more than 50%. B) Immunoblot analysis of H3K79 methylation levels in the two cell lines with and without inhibitors. Both the effect of the inhibitors and the difference between the cell lines can be observed. * indicates a lane that was underloaded because most cells had died.
